Remove Data Remove Packaging Remove Research and Development Remove Safety
article thumbnail

Press Release: Numinus Wellness research facility licensed by Health Canada to supply psilocybin mushrooms

Cannabis Law Report

Numinus Bioscience said that it is prepared to supply psilocybin in whole mushroom form, through three packaged doses equivalent to 10, 15, and 25mg of psilocybin. TSX-V:NUMI, OTC:LKYSF) said that its research facility– Numinus Bioscience– has been included on Health Canada’s list of federally licensed psilocybin producers.

article thumbnail

Press Release: Entheon Biomedical Announces EEG Patent Application & Provides Research Update

Cannabis Law Report

EBRX-101 on Track to Submit Regulatory Package for Human DMT Clinical Trial. The Company is pleased to confirm that it is on track to submit its regulatory package to the Dutch ethics committee in early 2022 for its upcoming human trial. . – December 16, 2021) – Entheon Biomedical Corp. About Entheon Biomedical Corp.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

The Economic Impact of the Medical Marijuana Industry: Trends and Projections

MMJ Recs

Economic Growth and Job Creation of the medical marijuana industry The medical cannabis sector serves as a catalyst for economic expansion and workforce development in regions where it’s legalized. This process involves various stages, including cultivation, processing, packaging, distribution, and retailing.

article thumbnail

Virpax Advances Envelta™ Development with NCATS Under CRADA Agreement

Cannabis Law Report

– Multiple Contracts Awarded to Support the Development and Manufacturing of Envelta (NES100) – BERWYN, Pa.–(BUSINESS as well as to support Good Laboratory Practices (GLP) toxicology, safety studies and preclinical efficacy studies. –(BUSINESS WIRE)– #pharma — Virpax ® Pharmaceuticals, Inc.

article thumbnail

Program Specialist 2 (Cannabis), Office of Cannabis Management 250 Broadway, New York

Cannabis Law Report

The Program Specialist 2 (Cannabis) positions will perform applicant and licensee inspection of physical facilities, adherence to program regulations, development of guidance documents and statement of findings and other duties ensuring licensees are complying with public health and safety best practices. Additional Comments.

article thumbnail

Oxford Cannabinoid Technologies Holdings plc – Pre-Close Trading Update; US OTC QB Market Application & Notice of 2021 Final Results

Cannabis Law Report

Notwithstanding the limited impact of the Covid-19 pandemic on the Group’s activities, very good progress has been made on advancements across all four current drug development programmes and OCTP remains firmly on target to achieve its timeline to commercialisation as set out in its IPO Prospectus published in May of this year.

article thumbnail

Zentrela, Inc. Welcomes Cannabis Industry Pioneer Jay McMillan to Advisory Board

Cannabis Law Report

a leading innovator in cannabis experience research for business and scientific applications, today announced that Jay McMillan, CEO of UberGreen Inc., McMillan is an accomplished corporate development and M&A executive with a passion for product innovation. HAMILTON, Ontario–(BUSINESS WIRE)– Zentrela Inc. ,